EPISODE · Jun 30, 2026 · 22 MIN
Pre vaccine lethality rates
from Dr. John Campbell · host Campbellteaching
Lower than previously thought Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand (16th March 2020) Imperial College COVID-19 Response Team https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf We assumed Incubation period of 5.1 days Infectious 12 hours before to 4.6 days after R0=2.4 Non-uniform attack, applied to the GB population Result in an IFR of 0.9% with 4.4% of infections hospitalised 10.4 day stay 30% of hospitalised, ICU (50% death rate) (not accounting for the potential negative effects of health systems being overwhelmed on mortality) Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies Stanford California, Rome, Montreal https://www.medrxiv.org/content/10.1101/2022.10.11.22280963v1 40 eligible national seroprevalence studies, covering 38 countries with pre-vaccination seroprevalence data. For 29 countries publicly available age-stratified COVID-19 death data, and age-stratified seroprevalence information were available, and were included in the primary analysis. IFRs for 0 to 59 years median IFR = 0.035% (IQR, 0.013 - 0.056%) Without accounting for seroreversion (average time from seroconversion to seroreversion at 3-4 months) IFRs for 0 to 69 years IFR = 0.095% 0 to 19 years IFR = 0.0003% 20 to 29 years IFR = 0.003% 30 to 39 years IFR = 0.011% 40-49 years IFR = 0.035% 50-59 years IFR = 0.129% 60-69 years IFR = 0.501% At a global level Pre-vaccination IFR, may have been as low as, 0 to 59 years = 0.03% 0 to 69 years = 0.07% Global population 94% younger than 70 years 91% younger than 65 years 86% younger than 60 years The current analysis suggests a much lower pre-vaccination IFR in non-elderly populations than previously suggested. Large differences did exist between countries and may reflect differences in comorbidities and other factors. These estimates provide a baseline from which to fathom further IFR declines with the widespread use of, Vaccination Prior infections Evolution of new variants. Unmitigated epidemic (March 2020) UK deaths = 510,000 (168,913) US deaths = 2.2 million (1,065,152) During 2021 and 2022 Vaccination, new variants, prior infections, resulted in a marked decline in the IFR Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Lower than previously thought Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand (16th March 2020) Imperial College COVID-19 Response Team https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf We assumed Incubation period of 5.1 days Infectious 12 hours before to 4.6 days after R0=2.4 Non-uniform attack, applied to the GB population Result in an IFR of 0.9% with 4.4% of infections hospitalised 10.4 day stay 30% of hospitalised, ICU (50% death rate) (not accounting for the potential negative effects of health systems being overwhelmed on mortality) Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies Stanford California, Rome, Montreal https://www.medrxiv.org/content/10.1101/2022.10.11.22280963v1 40 eligible national seroprevalence studies, covering 38 countries with pre-vaccination seroprevalence data. For 29 countries publicly available age-stratified COVID-19 death data, and age-stratified seroprevalence information were available, and were included in the primary analysis. IFRs for 0 to 59 years median IFR = 0.035% (IQR, 0.013 - 0.056%) Without accounting for seroreversion (average time from seroconversion to seroreversion at 3-4 months) IFRs for 0 to 69 years IFR = 0.095% 0 to 19 years IFR = 0.0003% 20 to 29 years IFR = 0.003% 30 to 39 years IFR = 0.011% 40-49 years IFR = 0.035% 50-59 years IFR = 0.129% 60-69 years IFR = 0.501% At a global level Pre-vaccination IFR, may have been as low as, 0 to 59 years = 0.03% 0 to 69 years = 0.07% Global population 94% younger than 70 years 91% younger than 65 years 86% younger than 60 years The current analysis suggests a much lower pre-vaccination IFR in non-elderly populations than previously suggested. Large differences did exist between countries and may reflect differences in comorbidities and other factors. These estimates provide a baseline from which to fathom further IFR declines with the widespread use of, Vaccination Prior infections Evolution of new variants. Unmitigated epidemic (March 2020) UK deaths = 510,000 (168,913) US deaths = 2.2 million (1,065,152) During 2021 and 2022 Vaccination, new variants, prior infections, resulted in a marked decline in the IFR Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Pre vaccine lethality rates
No transcript for this episode yet
Similar Episodes
Jun 30, 2026 ·98m
Jun 23, 2026 ·35m
Jun 16, 2026 ·100m
Jun 9, 2026 ·83m
May 26, 2026 ·94m